Surgical management in a patient with renal cell carcinoma with inferior vena cava thrombosis and antrialmetastasis – Case report and literature review  by Kuo, Ming-Chieh et al.
Abstracts / Urological Science 26 (2015) S50eS81 S53extremely rare. We report a case of nephrogenic adenoma arising from the
right lower ureter with clinical features suspicious of carcinoma
Materials andMethods: A 47 years old male, who complained about gross
hematuria with lower abdominal tenderness. KUB revealed Right M/3
ureter and renal echo revealed hydronephrosis. So URSL was arranged.
During operation, right lower third ureter papillary tumor with hyper-
vascular expression was noted. Urothelial carcinoma was impressed and
biopsy was done. However the pathological result revealed proliferation of
small, round to oval tubular structures lined by a regenerated urothelium.
The nuclei of these tubules did not show any mitotic activity. And neph-
rogenic adenoma is impressed. And he is free from disease for 6 months.
Results: Until now, nephrogenic adenoma is considered as a metaplastic
response of urothelium due to chronic irritation. The morphology of the
tumor is usually like urothelial carcinoma, with papillary expression and
hyper-vascular structure. However, under microscopic, therewas no nuclei
mitotic activity and immunohistochemically, the lesion was lake of CEA,
p53, cytokeratin 20. Nephrogenic adenoma is currently thought to have no
malignant potential. However, due to the risk of local recurrence, long term
follow up is suggested.
Conclusion: We present an extremely rare case that have nephrogenic
adenoma of ureter. And due to high risk of local recurrence with mass
effect related symptom, long term follow up may be needed.
NDP013:
STONE COMPONENT ANALYSIS OF 1000 PATIENTS IN YI-LAN COUNTY
Shyh-Chyi Chang 1,2, Hueih-Shing Hsu 1,2, Hsu-Hsiang Wang 1, Heng-Chang
Chuang 1, I-Hung Shao 1. 1Division of Urology, Department of Surgery, Lotung
Poh-Ai Hospital, Yi-Lan County, Taiwan; 2Department of Urology, School of
Medicine, National Yang-Ming University, Taipei, Taiwan
Purpose: The knowledge of urinary stone component plays an important
role in understanding pathophysiology, choice of treatment modality, and
prevention of recurrences of urolithiasis, Stone component revealed by
stone analysis study provides the information. We analyze the stone
analysis reports of 1000 patients in Yi-Lan county.
Materials and Methods: 1000 patients visited our hospital from Jan 2009
to Apr 2012 for urolithiasis treatment were included. Stone fragment
collected after extracoporal shock wave lithotripsy (ESWL), ureteroscopic
lithotripsy (URSL), percutaneous nephrolithotripsy (PCNL), vesicolitho-
tripsy, or other treatment procedure was sent for stone analysis study
(Fourier Transform Infrared Spectrophotometer, FTIR). Retrospective
analysis of patient gender, age, and the stone analysis data were evaluated.
Results: The average age of the 1000 patients is 53.1 year-old with 692
male patients. Pure single stone component (100%) of calcium oxalate,
calcium phosphate and uric acid were noted in 4.2%, 5.8%, and 7.0% pa-
tients with the male to female ratio as 83.33%, 48.28% and 84.29%. The
dominant stone component (>70%) of calcium oxalate, calcium phosphate
and uric acid were noted in 49.9%, 20.6%, and 7.6% patients. In 100 patients
with uric acid component, 70 patients belong to pure stone component
(100% uric acid). Protein calculi component was noted in 8 patients. 2 of
the patients have pure protein calculi. Cystine stone were noted in 1 pa-
tients with 100% cystine component.
Conclusion: In Yi-Lan county, most common stone component is calcium
oxalate. Near half patients have calcium oxalate component more than
70%. Compare to calcium oxalate and uric acid stone, calcium phosphate
stone were more common in female. Uric acid stone formed with high
purity. Further patient education in diet control and urinary tract infection
prevention seems to be important in prevent urolithiasis recurrence.
NDP014:
PARTIAL NEPHRECTOMY WITH VELA LASER IN RENAL CELL
CARCINOMA: CASE REPORT AND LITERATURE REVIEW
Ming-Hsiang Kuo, Kun-Hung Shen. Department of Surgery, Division of
Urology, Chi Mei Medical Center, Tainan, Taiwan
Purpose: Laser prostatectomy is increasingly being considered as a valid
clinical alternative to TURP which resulting in relatively low rates of
intraoperative and perioperative complications. Vela (1.9um thulium
laser) laser is also the optimum laser for interdisciplinary interventions inurology. We introduce a case or renal cell carcinoma receiving partial
nephrectomy with Vela laser.
Materials and Methods: This 48-year-old female patient had past history
of DM, HTN, Hyperlipidemia, Obesity (93 kg), left ureteral stone S/P URS-
SM, right ureteral stone s/p ESWL, right APN, Bilateral renal stones. She
suffered from gross hematuria for a month. The CTU showed: Right renal
nodule, exophytic nodular lesion about 2.2 cm. So she received right renal
biopsy on 2014/12/11. The pathology revealed: Clear cell renal cell carci-
noma(cT1aN0M0). Right retroperitoneal laparoscopic partial nephrectomy
with Vela laser was performed after discussing with the patient. Total
blood loss was 250 ml with warm ischemia time 30 mins. Post-operative
care was stable that she discharged on Post-operative Day 4. Pathology
was compatible with previous biopsy with free margin.
Conclusion: Laser its use in other endourology application or tumor
resection was relatively rare. We would like to introduce a case of our own
experience and the pros and cons compared with laparoscopic partial
nephrectomy in blood loss, surgical outcomes, length of hospitalization
and prognosis of disease control if available.
NDP015:
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WITH INFERIOR VENA CAVA THROMBOSIS AND ANTRIALMETASTASIS e
CASE REPORT AND LITERATURE REVIEW
Ming-Chieh Kuo 1,2, Steven Kuan-Hua Huan 1, Nan-Chun Wu2. 1Division of
Urology, Department of Surgery, Division of Uro-Oncology, Taiwan; 2Division
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Background: Patients with metastatic renal cell carcinoma (RCC) or who
develop metastases following prior treatment are generally managed with
systemic therapy, primarily using agents targeting the vascular endothelial
growth factor (VEGF) pathways. However, surgery continues to play an
important role in the management of these patients in some ways. A ne-
phrectomy can be a part of a combined approach to decrease the bulk of
tumor prior to systemic therapy, while a metastasectomy can be per-
formed in patients with one or a very limited number of metastases.
Case Report: We presented a 75 years-old gentleman who sufferedfrom
right renal tunorwith inferior vena cava thrombosis and right antrum
metastasis.The chief complaint was dyspnea and poor appetite for 6
months. For pending heart failure, surgical intervention including right
transperitonealredical nephrectomy andresection of inferior vena cava and
right antrial tumor was performed.
Conclusion: As metastasectomy of lung, bone, brain, and intra-abdominal
organs had been reported according to previous literature, clinical expe-
rience in metastasectomy of vascular system including major vessel and
heart was limited. We reviewed the management of these patients and
surgical outcome if surgical intervention was performed according to
previous literature.Urolithiasis
NDP016:
SINGLE CENTER, SINGLE OPERATOR COMPARATIVE STUDY
OF THE EFFICACY AND OUTCOMES OF ELECTROHYDRAULIC AND
ELECTROMAGNETIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPTORS
Chih-Chiao Lee MD, Ding-Po Lin MD.
Purpose: To compare the efﬁcacy and outcomes of two types of shock
wave machines, the electrohydraulic lithotriptor (E3000) and electro-
magnetic lithotriptor (EM1000), as treatment of upper urinary tract stones.
Materials and Methods: The efﬁcacy and outcomes of shock wave litho-
tripsy (SWL) using Medispec's E3000 electrohydraulic shock wave litho-
triptor (179 cases) and Medispec's EM1000 electromagnetic shock wave
lithotriptor (93 cases) in 272 patients with upper urinary tract stones
between January 2011 and June 2013 were reviewed. The same operators
performed all of the SWL treatments under the supervision of urologists in
a single center. The demographic features, treatment parameters (i.e.,
stone site and size), and complications for both lithotriptors were
analyzed. The patients were evaluated within 4 weeks after lithotripsy by
